Stockreport

Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus [Seeking Alpha]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF CEO Glendon French noted, “During the past few months, Derrick and I have taken a deliberate bottom-up approach to assess the business, building on what's working, addr [Read more]